About Half of Traditional Medicare Beneficiaries Are in ACOs, Says CMS
CMS said in a news release today that 13.7 million beneficiaries are in accountable care organizations (ACOs) and that a total of 480 ACOs are participating in the Medicare Shared Savings Program (MSSP).
Medicare accountable care organizations (ACOs) now include 13.7 million beneficiaries, or nearly half of the people in traditional Medicare, the Centers for Medicare & Medicaid Services (CMS) said today as part of announcement about ACO growth and enrollment.
Sixty-nine new ACOs are now participating in the Medicare Shared Saving Program (MSSP), CMS’ largest ACO program, according to the CMS news release. Nineteen of those newcomers are in a new payment option that includes advance investment payments for caring for beneficiaries in underserved populations
Counting the 71 ACOs that renewed their participation in the program, there are now 480 ACOs in MSSP, according to CMS.
The agency said that an additional 245 organizations are continuing to participate in two other valued-based programs, the ACO Realizing Equity, Access, and Community Health (ACO REACH) and the Kidney Care Choices (KCC) models.
The 19 ACOs receiving investment payments are required to invest in healthcare infrastructure and staffing that is supposed to improve healthcare for underserved beneficiaries. Hiring community health workers and utilizing health assessment and screening tools are among the steps they are taking to accomplish that goal, according to the news release.
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Conversations with Perry and Friends: Saar Mahna, J.D., MBA
July 31st 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the "Conversations with Perry and Friends" podcast. In this episode, Cohen speaks with Saar Mahna, J.D., MBA, CEO and founder of Banjo Health, an artificial intelligence company focused on prior authorization.
Listen
First-in-Class Therapy for Diabetic Retinopathy Shows Six-Month Benefit | ASRS 2025
July 31st 2025PER-001, delivered through a slow-release, dissolvable implant in the vitreous cavity of the eye, is designed to block endothelin signaling to increase ocular blood flow and prevent vision loss.
Read More
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
July 31st 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
